Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Balversa is specifically designed for patients with advanced urothelial carcinom···【more】
Release date：2024-08-28Recommended：217
Balversa is a targeted drug targeting FGFR mutations for the treatment of advanc···【more】
Release date：2024-08-28Recommended：249
Balversais an oral anti-tumor drug for the treatment of urothelial carcinoma wit···【more】
Release date：2024-08-28Recommended：189
Balversa is a new anti-cancer drug targeting FGFR, targeting urothelial carcinom···【more】
Release date：2024-08-28Recommended：238
Balversais an oral anti-cancer drug mainly used for the treatment of advanced or···【more】
Release date：2024-08-28Recommended：317
Balversais an anti-tumor drug for FGFR mutant tumors, which is usually administe···【more】
Release date：2024-08-27Recommended：234
Balversa is an innovative targeted therapy drug that is clinically used in patie···【more】
Release date：2024-08-27Recommended：240
Stipentol is an anti-epileptic drug that reduces seizures primarily by boosting ···【more】
Release date：2024-08-27Recommended：228
Alpelisib is the drug of choice for patients with PIK3CA-mutated breast cancer a···【more】
Release date：2024-08-27Recommended：267
In 2022, Alpelisib received accelerated FDA approval for patients on the PIK3CA-···【more】
Release date：2024-08-27Recommended：258
As the first oral small molecule drug for HR/HER2- and PIK3CA-mutated advanced b···【more】
Release date：2024-08-27Recommended：234
In 2022, Alpelisib received accelerated FDA approval for the treatment of adults···【more】
Release date：2024-08-27Recommended：222
